AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings

Abstract Studies have shown that the levels of pro-inflammatory adipokines in patients with psoriasis are higher than in general population. The aim of the study was to investigate the influence of 36-month therapy with TNF-α inhibitors (adalimumab, etanercept, infliximab) on the levels of adipokine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irmina Olejniczak-Staruch, Joanna Narbutt, Justyna Ceryn, Małgorzata Skibińska, Igor Bednarski, Anna Woźniacka, Joanna Sieniawska, Marzena Kraska-Gacka, Magdalena Ciążyńska, Janusz Śmigielski, Marcin Noweta, Michał Waszczykowski, Witold Owczarek, Adam Reich, Aleksandra Lesiak
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6ae076d2268848daa946d699e5b9a4de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ae076d2268848daa946d699e5b9a4de
record_format dspace
spelling oai:doaj.org-article:6ae076d2268848daa946d699e5b9a4de2021-12-02T17:15:17ZAntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings10.1038/s41598-021-88552-62045-2322https://doaj.org/article/6ae076d2268848daa946d699e5b9a4de2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88552-6https://doaj.org/toc/2045-2322Abstract Studies have shown that the levels of pro-inflammatory adipokines in patients with psoriasis are higher than in general population. The aim of the study was to investigate the influence of 36-month therapy with TNF-α inhibitors (adalimumab, etanercept, infliximab) on the levels of adipokines (resistin, adiponectin, leptin) and lipids (TG, cholesterol, LDL, HDL) in 37 psoriasis patients and 30 healthy controls. The mean serum concentrations of adiponectin in patients from adalimumab, etanercept and infliximab group were similar to control group (p > 0.05, 142.71, 164.32, 129.35 and 174.44 μg/ml respectively). Resistin levels were higher in patients (p < 0.05, 4.48, 4.53 and 3.39 ng/ml respectively) than in controls (3.05 ng/ml). Mean leptin concentrations were significantly higher (p < 0.05) in the study group than in subjects without psoriasis (428.61, 523.24, 755.27 and 154.10 pg/ml respectively). A significant decrease in the mean resistin concentration was observed under the influence of biological therapy (p < 0.05). Decrease in serum leptin level was noted in etanercept and infliximab groups (p = 0.001 and p = 0.002 respectively). Improvement in all lipidogram parameters was noted in all examined groups (p < 0.05). Results may prove that biologic therapy affects the systemic inflammation associated with psoriasis and this effect persists with long-term therapy.Irmina Olejniczak-StaruchJoanna NarbuttJustyna CerynMałgorzata SkibińskaIgor BednarskiAnna WoźniackaJoanna SieniawskaMarzena Kraska-GackaMagdalena CiążyńskaJanusz ŚmigielskiMarcin NowetaMichał WaszczykowskiWitold OwczarekAdam ReichAleksandra LesiakNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Irmina Olejniczak-Staruch
Joanna Narbutt
Justyna Ceryn
Małgorzata Skibińska
Igor Bednarski
Anna Woźniacka
Joanna Sieniawska
Marzena Kraska-Gacka
Magdalena Ciążyńska
Janusz Śmigielski
Marcin Noweta
Michał Waszczykowski
Witold Owczarek
Adam Reich
Aleksandra Lesiak
AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
description Abstract Studies have shown that the levels of pro-inflammatory adipokines in patients with psoriasis are higher than in general population. The aim of the study was to investigate the influence of 36-month therapy with TNF-α inhibitors (adalimumab, etanercept, infliximab) on the levels of adipokines (resistin, adiponectin, leptin) and lipids (TG, cholesterol, LDL, HDL) in 37 psoriasis patients and 30 healthy controls. The mean serum concentrations of adiponectin in patients from adalimumab, etanercept and infliximab group were similar to control group (p > 0.05, 142.71, 164.32, 129.35 and 174.44 μg/ml respectively). Resistin levels were higher in patients (p < 0.05, 4.48, 4.53 and 3.39 ng/ml respectively) than in controls (3.05 ng/ml). Mean leptin concentrations were significantly higher (p < 0.05) in the study group than in subjects without psoriasis (428.61, 523.24, 755.27 and 154.10 pg/ml respectively). A significant decrease in the mean resistin concentration was observed under the influence of biological therapy (p < 0.05). Decrease in serum leptin level was noted in etanercept and infliximab groups (p = 0.001 and p = 0.002 respectively). Improvement in all lipidogram parameters was noted in all examined groups (p < 0.05). Results may prove that biologic therapy affects the systemic inflammation associated with psoriasis and this effect persists with long-term therapy.
format article
author Irmina Olejniczak-Staruch
Joanna Narbutt
Justyna Ceryn
Małgorzata Skibińska
Igor Bednarski
Anna Woźniacka
Joanna Sieniawska
Marzena Kraska-Gacka
Magdalena Ciążyńska
Janusz Śmigielski
Marcin Noweta
Michał Waszczykowski
Witold Owczarek
Adam Reich
Aleksandra Lesiak
author_facet Irmina Olejniczak-Staruch
Joanna Narbutt
Justyna Ceryn
Małgorzata Skibińska
Igor Bednarski
Anna Woźniacka
Joanna Sieniawska
Marzena Kraska-Gacka
Magdalena Ciążyńska
Janusz Śmigielski
Marcin Noweta
Michał Waszczykowski
Witold Owczarek
Adam Reich
Aleksandra Lesiak
author_sort Irmina Olejniczak-Staruch
title AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
title_short AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
title_full AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
title_fullStr AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
title_full_unstemmed AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
title_sort antitnf-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6ae076d2268848daa946d699e5b9a4de
work_keys_str_mv AT irminaolejniczakstaruch antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT joannanarbutt antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT justynaceryn antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT małgorzataskibinska antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT igorbednarski antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT annawozniacka antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT joannasieniawska antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT marzenakraskagacka antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT magdalenaciazynska antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT januszsmigielski antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT marcinnoweta antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT michałwaszczykowski antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT witoldowczarek antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT adamreich antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
AT aleksandralesiak antitnfalphatherapynormalizeslevelsoflipidsandadipokinesinpsoriaticpatientsinthereallifesettings
_version_ 1718381263927115776